International Society of Surgery (ISS)

Société Internationale de Chirurgie (SIC)

Integrated Societies: IATSIC | IASMEN | BSI | ISDS

THELDENIYA TECHNIQUE OF ENDOSCOPIC THERMO-ABLATION (TETA) FOR ESOPHAGEAL CANCER kosala.medi@gmail.com

311-03
THELDENIYA TECHNIQUE OF ENDOSCOPIC THERMO-ABLATION (TETA) FOR ESOPHAGEAL CANCER
Author Details
2
Including the presenting author
Kosala Somaratne kosala.medi@gmail.com District Base Hospital Theldeniya Surgery Theldeniya Sri Lanka *
Thilanka Seneviratne thilanka.medi@gmail.com Faculty of Medicine, University of Peradeniya Pharmacology Peradeniya Sri Lanka
Kosala Somaratne
kosala.medi@gmail.com
Sri Lanka
Abstract
Oral or Poster
This new technique was devised to alleviate dysphagia in a) patients on palliation who are not amenable to stents due to very tight stricture b) patients who refuses surgery and other oncologic treatments c) patients in the work up, awaiting surgery
Malignant tissues were ablated using the endoscopic hot biopsy forceps keeping diathermy in SoftCoag 90watt settings. Channel is coagulated through the obstructing tumor. All patients were scored as per Functional Oral Intake scale (FIOS), pre-TETA and post-TETA. FIOS score 1-7, 1-total dysphagia. 7-no dysphagia, Patients who were on palliation were stented using covered stents after achieving adequate channel diameter
From July/2024 to July/2025 fourteen (14) patients underwent TETA. 11 on palliative pathway and 03 on pre-op work-up. All patients climbed at least two points in FIOS scale after TETA One patient remarkably climbed from 01 to 07 (i.e. from total dysphagia to no dysphagia at all). No patient had any esophageal perforation. Two patients underwent laparo-thoracoscopic esophagectomy (both without neo-adjuvant chemo-radiation as decided in MDT). Interestingly one patient had surgical specimen histology negative for malignancy, possibly pointing to TETA having a therapeutic value as well. This particular result if supported by further evaluations would be a possible breakthrough in the management of esophageal cancer.
TETA achieved good relief from dysphagia both in therapeutic and palliative settings in patients who were not amenable to esophageal stenting. There are early indications towards possible therapeutic value of TETA, which needs further evaluation.
https://storage.unitedwebnetwork.com/files/1258/e91c74a2c2d3e26fc7ea8434c08ab6be.jpg
Only accept images in .jpg or .png format. The image size must not exceed 1 MB.
https://storage.unitedwebnetwork.com/files/1258/d2f62d92a3c36d01b4caba9713bc27bd.jpg
Only accept images in .jpg or .png format. The image size must not exceed 1 MB.
Category
2 Digestive Surgery organized by ISDS
2.01 Upper Gastro-Intestinal Surgery
Submitted
240
Abstract Prizes
No
- Presenting author must register to the congress by 30 November 2025
- Author must submit a full-length manuscript conforming to the format of orignial articles in the World Journal of Surgery WJS by 30 November 2025
No
- Author must be age 40 or younger
- One of the authors must be a member of ISDS
- Presenting author must register to the congress by 30 November 2025
- Author must submit a full-length manuscript to the World Journal of Surgery WJS by 30 November 2025
No
- Author must be age 40 or younger
- One of the authors must be a member of ISDS
- Presenting author must register to the congress by 30 November 2025
- Author must submit a full-length manuscript to the World Journal of Surgery WJS by 30 November 2025